Business Standard

Wednesday, December 25, 2024 | 11:59 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Sun Pharma hits 5-month low; stock slips 7%

The stock dipped 7% to Rs 475, its lowest level since June 6, 2018 on the BSE.

Sun Pharma
Premium

FILE PHOTO: A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai | Photo: Reuters

SI Reporter Mumbai
Shares of Sun Pharmaceutical Industries hit an over five-month low of Rs 475 per share, slipping 7%, and falling 9% from its early morning high on Tuesday on the back of heavy volumes. The stock was trading at its lowest level since June 6, 2018, declining 11% in past three days.

Sun Pharma was up 2% to Rs 521 in intra-day trade after the drug maker said that it has settled Modafinil antitrust litigation with certain US plaintiffs.

“Sun Pharmaceutical Industries and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in the In re

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in